Prospective clinical trial of rifaximin therapy for patients with primary sclerosing cholangitis

Primary sclerosing cholangitis (PSC) is a rare, chronic, cholestatic liver disease in which emerging data suggest that oral antibiotics may offer therapeutic effects. We enrolled patients with PSC in a 12-week open-label pilot study to investigate the efficacy and safety of oral rifaximin 550 mg twi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Am J Ther
Hoofdauteurs: Tabibian, James H., Gossard, Andrea, El-Youssef, Mounif, Eaton, John E., Petz, Jan, Jorgensen, Roberta, Enders, Felicity B., Lindor, Keith D.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2017
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4261045/
https://ncbi.nlm.nih.gov/pubmed/24914504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MJT.0000000000000102
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items